Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform

scientific article published on 25 September 2018

Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/ACSNANO.8B02776
P932PMC publication ID6261714
P698PubMed publication ID30234973

P50authorJohn S KlassenQ87677701
Ming TanQ90231711
P2093author name stringLing Han
Ming Xia
Pengwei Huang
Xi Jiang
Wen Jiang
Weiming Zhong
Chen Sun
Kunpeng Li
Frank S Vago
P2860cites workThe P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptorsQ24563224
Rotavirus and severe childhood diarrheaQ24605360
Structural basis for the recognition of blood group trisaccharides by norovirusQ24682901
X-ray crystallographic structure of the Norwalk virus capsidQ27619935
Structural Basis for the Receptor Binding Specificity of Norwalk VirusQ27650214
Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virusQ27651029
Atomic model of an infectious rotavirus particleQ27666313
Crystal Structures of GII.10 and GII.12 Norovirus Protruding Domains in Complex with Histo-Blood Group Antigens Reveal Details for a Potential Site of VulnerabilityQ27667594
Structural Analysis of Histo-Blood Group Antigen Binding Specificity in a Norovirus GII.4 Epidemic Variant: Implications for Epochal EvolutionQ27670610
Crystallography of a Lewis-Binding Norovirus, Elucidation of Strain-Specificity to the Polymorphic Human Histo-Blood Group AntigensQ27671411
Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigenQ27678512
Unexpected fold in the circumsporozoite protein target of malaria vaccinesQ27678840
Structural Analysis of Determinants of Histo-Blood Group Antigen Binding Specificity in Genogroup I NorovirusesQ27682308
Global burden of childhood pneumonia and diarrhoeaQ28288886
Glycan Specificity of P[19] Rotavirus and Comparison with Those of Related P GenotypesQ28821791
Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategyQ30234848
Norovirus gastroenteritis, carbohydrate receptors, and animal modelsQ33701801
Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patternsQ33788719
Subviral particle as vaccine and vaccine platformQ33812653
Branched-linear and agglomerate protein polymers as vaccine platformsQ34064413
Norwalk virus assembly and stability monitored by mass spectrometry.Q34121907
The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptorsQ34123964
2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysisQ34227701
Structural requirements for the assembly of Norwalk virus-like particlesQ34335587
Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody ProductionQ34485266
Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particlesQ34724844
Systematic literature review of role of noroviruses in sporadic gastroenteritisQ34804404
Norovirus-host interaction: multi-selections by human histo-blood group antigensQ35146233
Structure determination of feline calicivirus virus-like particles in the context of a pseudo-octahedral arrangementQ35201812
A Unique Human Norovirus Lineage with a Distinct HBGA Binding InterfaceQ35683789
A Bayesian view on cryo-EM structure determination.Q35859527
Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cellsQ35896548
Rotavirus vaccines: update on global impact and future prioritiesQ35918823
Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific mannerQ35943850
Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirusQ36110059
Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigensQ36246385
Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenicQ36255811
Noroviral P particle: structure, function and applications in virus-host interactionQ36429481
Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virusQ36445296
A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirusQ36519453
Polyvalent complexes for vaccine developmentQ36792270
Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirusQ36914794
A dual vaccine candidate against norovirus and hepatitis E virusQ37502688
Viral nanoparticles and virus-like particles: platforms for contemporary vaccine designQ37792984
Virus-like particle-based human vaccines: quality assessment based on structural and functional propertiesQ38152530
Histo-blood group antigens: a common niche for norovirus and rotavirusQ38194256
Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trialQ38797322
Recent advancements in combination subunit vaccine developmentQ38819439
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trialQ38879736
Detailed analysis of BALB/c mice challenged with wild type rotavirus EDIM provide an alternative for infection model of rotavirusQ39118286
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trialQ39944921
Gctf: Real-time CTF determination and correctionQ41603517
Intussusception risk after rotavirus vaccination in U.S. infantsQ42232989
Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries).Q45274597
Risk of intussusception after monovalent rotavirus vaccinationQ46186510
Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometryQ46851930
Rotavirus vaccines--balancing intussusception risks and health benefitsQ47119066
Effect of Human Rotavirus Vaccine on Severe Diarrhea in African InfantsQ57530944
P433issue11
P921main subjectnanoparticleQ61231
P304page(s)10665-10682
P577publication date2018-09-25
P1433published inACS NanoQ2819067
P1476titleBioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform
P478volume12

Reverse relations

cites work (P2860)
Q104289416Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine
Q92759295Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice
Q90231715Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development

Search more.